Flutamide (2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-propanamide) is a non-steroidal drug that has a specific anti-androgenic activity so that it is used in the treatment of prostate cancer. A simple method for extraction and detection of flutamide from pharmaceutical forms are reported using Soxhlet apparatus combined electrospray ionization tandem mass spectrometry (ESI(À)-MS n , n = 1À4) in negative ion mode. Spectra show a fingerprint peaks corresponding to flutamide. Propanamide moiety plays important role in structure elucidation. The diagnostic ions produced a useful fingerprint maps to identify flutamide in unknown samples. Furthermore, the proposed ions may help in the metabolite studies of the drug. The method proposed here is easy, cheap and applicable for large quantity.
Introduction
Flutamide (FLA) is an oral non-steroidal anti-androgen drug [1] that used to treat prostate cancer. IUPAC name of the drug is 2methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-propanamide with nominal mass 276.2 g/mol. FLA competes testosterone, dihydrotestosterone (DHT) for binding to androgen receptors in the prostate gland. The combination of FLA with luteinizing hormone-releasing hormone agonist or orchiectomy showed significant prolongation of survival of prostate cancer patients [2] . FLA may also be used to treat excess androgen levels in womenespecially those with PolyCystic Ovarian Syndrome (PCOS) [3] . 2-Hydroxy flutamide (antiandrogen) is the active metabolite of FLA that competitively blocks androgen action accessory sex organs and on pituitary-increased luteinizing hormone LH and follicle-stimulating hormone (FSH) secretion by blocking feedback inhibition and also decrease the metabolism of C-19 steroids by the cytochrome p-450 system [4] . Plasma testosterone levels increase in males which partially overcome the direct antiandrogen action of flutamide. It has been found to be palliative in advanced prostatic carcinoma [5] but it is better used in conjunction with GnRH against (to suppress LH and testosterone secretion) after castration. Along with oral contraceptives, it has been tried in female hirsutism. Thus, FLA was included in the United States Pharmacopoeia investigated by chromatographic separation [6] , polarography [7] , gas-chromatography (GC) [8] , high performance liquid chromatography (HPLC) [9] [10] [11] , photochemistry [12] , voltammetric [13] and electroanalytical methods [14] and others [15] [16] [17] . However, few of the above methods were ever applied for characterization and elucidation of the FLA structures from its pharmaceutical formulations. Therefore, sensitive detection of the degraded products of FLA would be very useful for understanding the role in vivo for the diagnosis of prostatic carcinoma and other related disorders. Electrospray ionization tandem mass spectrometry (ESI-MS/MS) is very helpful in drugs studies [18] .
Among the different analytical techniques, mass spectrometry is superior for drug/organic molecules detections [19] [20] [21] [22] [23] [24] [25] . It is simple, easy, sensitive, and give information about the structure. Furthermore, it is convenient to conjugate with separation techniques such as gas chromatography (GC), HPLC or others separation techniques. However, it is destructive. Moreover, it is trivial limitation for soft ionization such as matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS) and ESI-MS [26] [27] [28] [29] [30] [31] [32] [33] . It is also not require any further chemicals [34] [35] [36] .
The main targets of the present report are separation and elucidate the fragmentation of flutamide from its pharmaceutical formulation using ESI-MS n . A map of the drug fragmentation is elucidated for simple and accurate detection of FLA. Soxhlet apparatus was used to extract the drug from the pharmaceutical formulation. The efficiency of the extraction was evaluated using HPLC and authentic sample. The extracted drug was detected using ESI-MS n . The drug fragmentation was undergoes tandem mass in order to elucidate the drug structure. The data show unexpected peaks can be used as fingerprint of the drug. 
Experimental section

Reagents and samples
The pure flutamide (standard) was purchased from Echo Chemical Company (Kaohsiung, Taiwan). A commercial dosage (Eulexin) form of flutamide was purchased from the local pharmaceutical market (Kaohsiung, Taiwan). Methanol was purchased from Mallinckrodt (Phillipsburg, NJ, USA). The deionized water was purified on a Milli-Q reagent water system (Millipore, Milford, MA, USA). All other reagents and solvents used were of analytical grade. ACD/ChemSketch vs12 program was used to draw and calculate the theoretical mass of the chemical structures of the m/z peaks.
Extraction of flutamide
Ten commercial tablets of FLA were powdered, mixed thoroughly and dissolved in methanol, which is then extracted by using soxhlet extractor [37]. The extraction solvent (methanol) was continuously cycled through the sample by distilling the solvent to condense centered over the thimble. The condensed solvent permeated through the matrix and the thimble and was siphoned back into the pot, where it was recycled. The extracted material was concentrated in the pot by evaporating the solvent using low temperature and reduced pressure for rapid solvent removal. Recrystallization of an extracted drug was performed by using the same solvent.
Instrumentations
Chromatographic conditions
The HPLC experiments were performed on Waters 2795 module chromatographic system using diode array as the UV detector. The symmetry column C18, 4.6 Â 75 mm, 3.5 lm (Waters Corporation, Milford, USA) was used for analysis. The mobile phase used was acetonitrile (A) with buffer (B) containing 0.05% ammonium acetate in water with gradient system - 
ESI-tandem mass spectrometry detection
All experiments were performed in an ion trap tandem mass spectrometer (Thermo Finnigan LCQ-Advantage, San Jose, CA, USA) equipped with an ESI source. All ESI(À)-MS spectra were acquired in the negative ion mode. Samples were introduced through a 0.5 mm i.d. stainless steel heated capillary (12 cm length; 15-20 V) at a flow rate of 5 L/min. The spray voltage of 5 kV was applied to the tip of capillary, which is situated within the ionization source of the mass spectrometer. A potential of 15-25 V was applied to a focusing stainless steel tube lens located at the end of the capillary. Ions from the source are guided into an ion trap mass analyzer, which is operated with automated gain control (AGC) on, for all experiments. In this mode, the instrument can automatically select the best trapping parameters to keep the number of the ions present in the trap at a constant value in order to avoid space charge effects. The ion trap is operated in the massselective instability mode. All MS n experiments were performed by tuning the percentage of collision activated dissociation (CAD) voltages in order to optimize the dissociation energy for the precursor ions. An aliquot of 10 ppm of extracted solution of FLA in methanol was injected into the mass spectrometer. The scan range of mass spectra is from m/z 50 to 500. All experiments were repeated at least three times to ensure the reproducibility.
Results and discussion
Separation or extraction of the drug from their pharmaceutical formulation is highly demanded for detection [38] . Systematic representation of the drug extraction is shown in Scheme 1A. Because of the limit solubility of flutamide, Soxhlet extraction is used. Typically, Soxhlet is also make the impurity is insoluble in that solvent. The extracted drug is elucidated by electrospray ionization mass spectrometry (ESI-MS). The efficiency of the Soxhlet separation is evaluated HPLC. In order to elucidate the total peaks of the drug, tandam mass was investigated.
HPLC separation and detection on the commercial dosage of FLA
The purity of the extracted drug was found to be 99.47% determined by HPLC experiments Fig. S1 (Supporting information). The retention time of the FLA separated from the commercial dosage by HPLC with the UV detector (k max = 254 nm) was observed at 4.70 min (Fig. S1 ). The absorption refers to the B-band of the benzene ring. The high purity of the extracted flutamide indicates the high efficiency of Soxhlet.
ESI(À)-MS detection of FLA
The ESI(À)-MS results of the extracted (tablets) and pure FLA (standards) are shown in Fig. 1A and Fig. 1B , respectively. Compared with the standard FLA, the ESI(À)-MS results of the FLA tablets are in agreement with those of the standard FLA in regards to the formation ions. The assignments of ESI(À)-MS ions are listed in Table 1 35 Cl] À , [M+ 37 Cl] À respectively. The ions at m/z 310.7 and 312.7 are chlorine isotopic patterns of the adduct ion of the drug with ubiquitous ion (Cl À ). The intensity ratio between peaks at m/z 310.7 and 312.7 is $3:1 which is in agreement with the same ratio of Cl 35 :Cl 37 = 3:1 (see Eq. (1)). The two peaks can be used as fingerprints for identification of FLA in negative mode. The ESI(À)-MS shows a product ion at m/z 364.61 in both pure and extracted flutamide spectrum Fig. 1A and B . The structure of this peak is unexpected, so we master MS 2 , and MS 3 to elucidate the structure. Cl 35 Cl 37 ¼ Intensity of peak 310:75 Intensity of peak 312:75 ¼ 9; 000; 000 2; 950; 000
High order tandem ESI-MS results of FLA
The major metabolite of FLA in plasma is 2-hydroxyflutamide (OH-flutamide), whose formation from flutamide is catalyzed by CYP1A2 [39, 40] . Whereas the main metabolite in urine is 2amino-5-nitro-4-(trifluoromethyl) phenol (FLU-3) [41] . A new metabolite, N-[4-nitro-3-(trifluoromethyl) phenyl]hydroxylamine (FLU-1-N-OH), was detected as a product of the reaction of FLU-1 with human liver microsomes and identified by comparison with the synthetic standard. The formation of FLU-1-N-OH was markedly inhibited by the addition of miconazole, an inhibitor of CYP3A4, and was mediated by recombinant CYP3A4 [42] . Microbial models retrospectively of mammalian metabolites of flutamide investigated which may help to identify factors responsible for toxicity [43] . The MS/MS results on the main ESI-MS product ions of m/z 275.1, 310.0 and 364.0 are shown in Table 1 Fig. 2A) . In this rearrangement, a stable hexagonal ring formed that provides high stability of the anion according to Baeyer Strain theory and the development of Strain Theory [44] . The m/z 205.0 ([M-C 4 H 6 O-H] À ) ion undergoes hydrogen extrusion and to form azepine ring (seven nitrogen ring) that demonstrate high stability. Simply, this peak is deprotonated aniline derivative. Formation of 1,3-benzoxazole aromatic system results in the m/z 231.7 have high intensity due to the aromatic system stabilization energy ( Fig. 2A) . MS 3 and MS 4 of precursor m/z 310.7 are reported in Fig. 3B and C. This precursor fragmentation was described in Scheme 1B.
Peak at m/z 364.6 is unexpected, so we master MS 2 , MS 3 , and MS 4 to propose a reasonable structure of this peak. If we recheck Fig. 1A, B again (which observed in both extracted and pure flutamide, respectively), we observe presence of the peak at m/z Table 1 Observed product ions in ESI(À)-MS n mass spectra of extracted flutamide. Table 1 .
ESI(À)-MS
Comparison among the different technique that reported for flutamide detection is tabulated in Table 2 . ESI-MS n is sensitive, simple, rapid and gives information about the drug structure. However, visible spectrophotometric is simple, rapid, precise, sensitive, and accurate for the estimation of flutamide in both pure and pharmaceutical preparations [45] . It cannot give information about the drug structure. Recently (2014), Aslam et.al reported a simple and sensitive spectrophotometric method for the determination of flutamide (FLD) [46] . The method is based on its complexation and oxidation of FLA by Fe 3+ and 1,10-phenanthroline. However, it required extra chemical i.e., Fe 3+ and 1,10-phenanthroline. Based on the reduction of the nitro organic moiety of the drug molecule using cathodic stripping voltammetric at the hanging mercury drop electrode was optimized for determination of flutamide in bulk, tablets, and human [47] . However, mercury is highly toxic and hydrogen overpotential is limit the concentration detection.
Conclusion
We successfully introduce a rapid and simple method to detect the flutamide from its formulation. Furthermore, this study has demonstrated that high order electrospray tandem mass spectrometry (ESI(À)-MS n , n = 1-4) can be employed in negative ion mode. The Soxhlet apparatus combined ESI-MS n can elucidate the structures and study the fragmentation patterns of commercial FLA drugs. Subsequent MS n experiment reveals the liability of the propanamide group attached to the phenyl ring and inertness of trifluoromethyl moiety. Proponamide group plays also role to detect flutamide from any pharmaceutical formulation. This can be proved by peak at m/z 364.6 as a fingerprint. The diagnostic ions can be used as fingerprint maps to identify FLA in unknown samples. The current approach is an effective technique to analyze the drugs in commercial dosage forms. Furthermore, ESI(À)/MS map allows the analysis of the drug in environmental or biological samples. The assigned peaks may help in metabolite studies. 
